Arkolith/Insider Trading/TRAX/Form 4

Tamboli Ajim

Chief Financial OfficerFirst Tracks Biotherapeutics, Inc. (TRAX) · full profile →Form 4 · filed Apr 23, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
4
0 non-derivative · 4 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Apr 23, 2026Grant(A)41K—$041K
Apr 22, 2026Grant(A)41K—$041K
Apr 21, 2026Grant(A)46K—$046K
Apr 21, 2026Grant(A)41K—$041K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001855684-26-000007) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML